Home›Search›Molecular Neurodegeneration

Molecular Neurodegeneration

BioMed Central Ltd · United Kingdom · Est. 1987

ISSN1750-1326eISSN1750-1326

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

232

days submission → published

measured · last 19 articles · accept 198d

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

6.262

H-Indexi

164

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

2.64

Total Worksi

1,555

Total Citationsi

114,683

2yr Mean Citednessi

14.80

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Compiled from public sources

Molecular Neurodegeneration is a peer-reviewed, open access journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels. It covers neurodegenerative diseases, prion diseases, dementia, and ageing. The journal also explores research in microglia and neuroinflammation, and genetically modified mouse research as part of transgene research.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1987

Annual Volume~ 110 articles / year

StatusActive (last: 2026)

Total Publications1,555

Publisher OrgBioMed Central

OA Since2005

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~12 weeks

Acceptance Rate—

OA LicenseCC BY, CC0

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

British Library; Koninklijke BibliotheekCLOCKSSLOCKSSPorticoPMC

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

BioMed Central Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1750-1326 / 1750-1326

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

British Library; Koninklijke Bibliotheek, CLOCKSS, LOCKSS, Portico, PMC

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

10k

2019

8.5k

2020

7.6k

2021

6.5k

2022

100

2023

100

2.9k

2024

130

1.7k

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cellular and Molecular NeuroscienceQ1

Molecular BiologyQ1

Neurology (clinical)Q1

Subject Classification

Web of Science Categories

Neurosciences

Scopus Categories

Neurology (clinical)Cellular and Molecular NeuroscienceMolecular Biology

Research Topics (OpenAlex)

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and TreatmentsAmyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment ResearchGenetic Neurodegenerative DiseasesNeurogenesis and neuroplasticity mechanismsNuclear Receptors and SignalingCholinesterase and Neurodegenerative DiseasesNeuroscience and Neuropharmacology Research

Frequently asked questions about Molecular Neurodegeneration

Is Molecular Neurodegeneration a predatory journal?

PubScope has no integrity flags on record for Molecular Neurodegeneration: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Molecular Neurodegeneration?

Molecular Neurodegeneration is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 14.80.

Is Molecular Neurodegeneration indexed in Scopus and Web of Science?

Molecular Neurodegeneration is indexed in Web of Science, Scopus, DOAJ.